CPH 0.00% 0.9¢ creso pharma limited

share price, page-26

  1. 71 Posts.
    lightbulb Created with Sketch. 8
    Very interesting article on Bloomberg and the Canadian market. Impressive figures and forecasts for the Med. M. Industry. Although by comparison, CPH is small compared to the large companies listed, it was a great move of management to put a foot on Canadian soil. Columbia will be very interesting for the South American market, IMO. Excellent strategy to be prepared when the market opens and you are in a position to supply.
    I will be one of the first to stand in line to buy CanaQix when it hits the drug stores 1Q18 here in Switzerland. Canabidiol is available at the vets here and looks like pet owners are enthusiastic. I don´t expect it to influence revenue greatly in the first reporting quarter, but mid-term and once available in other countries, will have a bright future. (Switzerland is a small market, approx. 8 million, but generally well informed).
    2018 will continue be a very suspenseful year and I hope it will be a prosperous, healthy and happy (CPH) one for all.
    From sunny but cold and partially white Switzerland.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.